R&D Tax Incentive Loan Facility Extension
Filed with ASX · · 1 page · English
Summary by 6ix AI
The loan facility, originally due at the end of September, will now mature at the end of November. The company has submitted its R&D Tax Incentive claim and expects to receive a rebate soon, which will be used to repay the loan.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Notification under Listing Rule 4.3D
- Appendix 4E & Preliminary Final Report
- June 2026 Quarterly Activity Report & Appendix 4C
- Board, Management Changes, Expenditure Reductions, RDTI Loan
- Reinstatement to Official Quotation
Later from Cynata Therapeutics
- Cynata Receives R&D TI Refund & Repays R&D TI Loan
- Termination of At-the-Market Subscription Deed
- Entitlement Offer & Unmarketable Parcel Sale Facility
- Prospectus
- September 2026 Quarterly Activity Report & Appendix 4C
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics